that labor Thank of you, to said first participants and Michael. higher XXXX some The spending have during will make to elevated, and prior expect rate being we our market interest as consumer will we the That it either continued remain as in expected. dramatically continue as calls, the slow environment half have persist. near-term, soon resilience view on as market inflation of the we the the economy over unlikely or said, believe strong
negotiate lower While and direct historical call compelling investment are enhanced levels during for environment. second the quarter remained opportunities see quality a high we strong lending compared averages, protection, attractive and to overall in pricing, to lower activity to companies. investment other investors private continue able leverage debt We
the many Given be portfolio choppy to private the companies. the sponsors is to we and markets, poised credit financing debt primary believe of nature still continue syndicated alternative for
mentioned, appears Michael seen M&A an increase as have recently, in flow activity to be we up. picking As deal
the to until the financial new given not of materially this associated results quarter However, increased year levels. fourth we year. perhaps in timeline activity the remind traditional see with will pleased increase the investment investments, are or early activity Nevertheless, we recent would investors likely next our impact that new
to Turning activity. investment
long-term portfolio $XXX investments. our million KKR add-on companies During primarily originated on relationships. the investments surprisingly, quarter, Not to were focused second of we and new financings existing
we quarter, M&A a second go part environment. to our to proactive of was the as we sought of capacity sale investment the view on during increase third-party This million based investments. on accelerating completed lower $XXX yielding our approximately forward our of the sale Additionally,
$XXX As a million million sales decrease with to new our portfolio $XXX opportunistic of million. portfolio equated result, and combined net $XXX of when investments repayments a of
dermatology for The company markets in the deployment over-the-counter the and and an receivable manufactures, at opportunities, the recent Bausch of financing closed Company. end eye we a medical range quarter, terms health and device, space. Health of products develops, of pharmaceutical, In facility primarily account
provided the balance investment accounts undrawn for points are off We backed receivable basis X.X% pharmaceutical financing upfront who was and fee. sheet with plus from a XXX by fees distributors. facility XX sold point with $XXX grade their Pricing million customers basis a company
and million example opportunities committed $XXX to in finding ABL of million transaction – in growing to we environment. are has This we corporate of compelling FSK is the funded type $XX and investment financing strategy current which an the date. our
an optimize reasonable outlook meaningful unitranche with asset-based asset-based begin seeing M&A traditional balance in with Additionally, business, the banks the particularly Combining our improved activities their half year. recent sheets. increase associated focus financings our to to we we for market finance of second given the finance are improving as on pressure opportunities on the the creates traditional
the quarter, a interest our had portfolio end of of interest at of companies terms coverage, the X.X coverage median times. second In
For uses better base March company to align clarity, portfolio this calculation rates XX, with as financials. of XXXX,
of forward-looking companies, deep weighted are XXXX. to positioned. our average XX, focus believe perspective, is EBITDA our In and well portfolio with which These continue evidenced high-quality operating cushions. we From our on margins as by statistics June part, strong borrowers equity the portfolio $XXX a million large in was due to
companies, portfolio XXXX. since have April X% weighted growth which companies invested we reported of a our average EBITDA year-over-year rate Additionally, in across of approximately
that, I’ll to our with turn to detail. in portfolio discuss more Brian over And call the